Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
ADMA Biologics Inc Stock Forecast NASDAQ:ADMA
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2021-11-11 | 141.55% | Raymond James | $5.00 | Upgrades | Outperform Strong Buy |
| 2021-11-09 | 117.39% | Cantor Fitzgerald | $4.50 | Initiates Coverage On | Overweight |
| 2021-10-26 | 141.55% | Raymond James | $6.00 $5.00 | Maintains | Outperform |
| 2021-08-12 | 189.86% | HC Wainwright & Co. | $7.00 $6.00 | Maintains | Buy |
| 2021-07-06 | 238.16% | HC Wainwright & Co. | $10.00 $7.00 | Maintains | Buy |
| 2021-03-26 | 189.86% | Raymond James | $7.00 $6.00 | Maintains | Outperform |
| 2021-01-04 | 431.4% | HC Wainwright & Co. | $12.00 $11.00 | Maintains | Buy |
| 2020-10-01 | 238.16% | Raymond James | $9.00 $7.00 | Maintains | Outperform |
| 2020-05-07 | 238.16% | Oppenheimer | $14.00 $7.00 | Maintains | Outperform |
| 2020-03-16 | 479.71% | HC Wainwright & Co. | $14.00 $12.00 | Maintains | Buy |
| 2019-06-04 | 286.47% | Jefferies | $8.00 | Initiates Coverage On | Buy |
ADMA Stock Trend
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled.
Given the current short-term trend, the stock is expected to rise 17.14% during the next 3 months and, with a 90% probability hold a price between $1.73 and $2.68 at the end of this 3-month period.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-25 | $1.48 | $1.89 | $2.30 |
| 2022-05-26 | $1.48 | $1.89 | $2.30 |
| 2022-05-27 | $1.49 | $1.90 | $2.31 |
| 2022-05-31 | $1.50 | $1.90 | $2.31 |
| 2022-06-01 | $1.50 | $1.91 | $2.32 |
| 2022-06-02 | $1.51 | $1.92 | $2.32 |
| 2022-06-03 | $1.51 | $1.92 | $2.33 |
| 2022-06-06 | $1.52 | $1.93 | $2.33 |
| 2022-06-07 | $1.52 | $1.93 | $2.34 |
| 2022-06-08 | $1.53 | $1.94 | $2.35 |
| 2022-06-09 | $1.53 | $1.94 | $2.35 |
| 2022-06-10 | $1.54 | $1.95 | $2.36 |
| 2022-06-13 | $1.55 | $1.95 | $2.36 |
| 2022-06-14 | $1.55 | $1.96 | $2.37 |
| 2022-06-15 | $1.56 | $1.96 | $2.37 |
| 2022-06-16 | $1.56 | $1.97 | $2.38 |
| 2022-06-17 | $1.57 | $1.98 | $2.38 |
| 2022-06-21 | $1.57 | $1.98 | $2.39 |
| 2022-06-22 | $1.58 | $1.99 | $2.39 |
| 2022-06-23 | $1.58 | $1.99 | $2.40 |
| 2022-06-24 | $1.59 | $2.00 | $2.41 |
| 2022-06-27 | $1.59 | $2.00 | $2.41 |
| 2022-06-28 | $1.60 | $2.01 | $2.42 |
| 2022-06-29 | $1.61 | $2.01 | $2.42 |
| 2022-06-30 | $1.61 | $2.02 | $2.43 |
| 2022-07-01 | $1.62 | $2.02 | $2.43 |
| 2022-07-05 | $1.62 | $2.03 | $2.44 |
| 2022-07-06 | $1.63 | $2.04 | $2.44 |
| 2022-07-07 | $1.63 | $2.04 | $2.45 |
| 2022-07-08 | $1.64 | $2.05 | $2.46 |
ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate is RI-002, a plasma-derived, polyclonal immune globulin intravenous that is in Phase III clinical study for the treatment of primary immune deficiency disease. The company also operatesADMA BioCenters Georgia, Inc, which is a... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
